Skip to main content
PharmaCielo Ltd. logo

PharmaCielo Ltd. — Investor Relations & Filings

Ticker · PCLO ISIN · CA71716K1012 LEI · 5493002XOFWMT83TYQ57 TSXV Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2021-05-13 Regulatory Filings
Country CA Canada
Listing TSXV PCLO

About PharmaCielo Ltd.

https://www.pharmacielo.com/

PharmaCielo Ltd. is a global supplier specializing in the cultivation, processing, and distribution of medicinal-grade cannabis extracts and dried flower. The company focuses on ethical and sustainable production, aiming to be a leading partner in the global medicinal cannabis market. Utilizing ideal equatorial conditions, PharmaCielo operates large-scale, high-efficiency production facilities, including 12 hectares of open-air greenhouses, enabling four full crops annually for reliable supply. Its product portfolio includes standardized extracts, such as high-purity CBD Isolate, and both psychoactive and non-psychoactive derivatives. Production adheres to pharmaceutical-quality standards, supported by proprietary genetics maintained in a tissue culture lab and advanced processing facilities ensuring consistency and safety.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2021-05-13 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from PharmaCielo Ltd. providing an update on its global GMP compliance process and sales pipeline progress. It discusses scheduled and completed GMP validation audits in various countries, the company's sales strategy, and forward-looking statements about expected outcomes. There are no financial statements, detailed financial performance data, or regulatory filings such as annual or quarterly reports. The content is primarily an operational update and business progress announcement rather than a formal financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Audit Report. It is also not a management or board change announcement, nor a legal or capital market update. The document is a corporate news announcement about business progress and compliance status, typical of a Regulatory Filing (RNS) as a general regulatory announcement and business update that does not fit other specific categories.
2021-05-05 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2021-05-03 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2021-05-03 English
News release - English.pdf
Regulatory Filings
2021-05-03 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing initial shipments of PharmaCielo's products to customers in Brazil, highlighting compliance with GMP standards and market potential. It contains no financial statements, regulatory filings, or detailed financial data. It is a corporate announcement about business operations and market development rather than a financial report, management change, or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is best classified as a general Regulatory Filing (RNS) since it is a corporate news announcement that does not fit other specific categories.
2021-04-26 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.